AC Immune Inc (ACIU) Company Projected Revenue
The target product realization level in the indicator's chronology on the GURU.Markets chart correlates with the colossal costs and risks associated with developing Alzheimer's drugs. The high authority of AC Immune (ACIU) in targeted therapy is confirmed by partnerships with industry leaders. Meanwhile, 0.03 captures the current value of the indicator as the company attracts elite neurobiologists through RSUs and stable R&D funding.
Metric breakdowns and analytics for AC Immune S.A. (ACIU)
- current price and projected stock value:
- market capitalization details:
- balance sheet equity data:
- business debt structure and liquidity details:
- earnings and market ratios statistics:
ACIU - Company Net Income|Future Profit AC Immune|ACIU - P/E Multiple|Future Price to Earnings AC Immune SA|ACIU - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AC Immune S.A.|ACIU - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) AC Immune|ACIU - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth acimmune.com|ACIU - Net earnings per share growth this year|Expected earnings per share growth for next year AC Immune
- sales and revenue data:
Basic company analysis:AC Immune ACIU
A comparative asset analysis requires an assessment of potential revenue by discounting expected cash flows from future commercial drug launches. This model measures the probability of monetizing R&D assets, which for AC Immune (ACIU) is supported by its authority in Alzheimer's disease therapy and partnerships with pharma behemoths, determining the company's final projected sales level.
Analysis of competing companies
Company Future Sales Volume BIIB (Biogen Inc.)|Projected Sales Volume neurocrine.com (NBIX)|Company Projected Revenue Regencell Bioscience Holdings Limited RGC|AXSM: Company Revenue Forecast|ACADIA Pharmaceuticals Inc - Projected Sales Volume|Company Expected Sales Volume Xenon Corp|VKTX: Projected Sales Volume|supernus.com (SUPN) - Projected Sales Volume|CPRX (Catalyst Pharmaceuticals, Inc.) - Projected Sales Volume|Company Future Sales Volume Denali (DNLI)|Projected Sales Volume HRMY|Company Future Sales Biohaven Corp|Amylyx Pharmaceuticals - Company Future Sales Volume|Projected Sales Volume trevitherapeutics.com TRVI|PRAX - Company Projected Revenue|AVXL (Anavex) - Company Revenue Forecast|CBLL: Projected Sales Volume|Company Expected Sales Volume Prothena Corp (PRTA)|Company Future Sales Volume ALEC|Projected Sales Volume annexonbio.com|Company Projected Revenue Omeros Corporation (OMER)|NGNE (Neurogene Inc) - Company Future Revenue|Company Projected Revenue Voyager Pharma VYGR|Neumora Corp (NMRA) - Company Expected Sales Volume|Scilex Holding Company - Projected Sales Volume|TVGN - Projected Sales Volume|ACOG: Projected Sales Volume|Company Future Sales Volume cogrx.com|Company Future Sales Volume IKT|SAVA: Company Future Revenue|Projected Sales Volume ASRT|Company Future Sales coyatherapeutics.com|Company Projected Revenue Vistagen VTGN|OVID - Company Future Sales Volume|ABOS - Company Projected Revenue|CervoMed Corporation (CRVO) - Company Future Sales Volume|ATHE (alteritytherapeutics.com) - Company Future Sales Volume|Clene (CLNN) - Projected Sales Volume|Company Projected Revenue PepGen Inc|Company Revenue Forecast JUNS (jupiterneurosciences.com)|Projected Sales Volume RLMD|ANVS - Company Expected Sales Volume|Projected Sales Volume GRCE (Grace Therapeutics)|Projected Sales Volume fireflyneuro.com AIFF|ANEW Medical, Inc. - Projected Sales Volume|NeuroSense Therapeutics (NRSN) - Company Future Sales Volume|RVPH: Projected Sales Volume|MTVA - Company Future Sales|Company Future Sales Volume NRXS|Projected Sales Volume Helius Medical Technologies Inc.|Company Projected Revenue Passage Bio, Inc. (PASG)|bionomics.com.au - Company Revenue Forecast|Projected Sales Volume NERV (Minerva Neurosciences Corp)|Athira Pharma Corp (ATHA) - Company Expected Sales Volume|ADXN: Company Future Sales Volume|ALZN - Projected Sales Volume|cyclerion.com (CYCN) - Company Projected Revenue|Protagenic Therapeutics, Inc. - Company Future Revenue|Company Projected Revenue Pasithea Therapeutics Corp|Company Expected Sales Volume Cortigent Medical CRGT|Projected Sales Volume ATXI|Projected Sales Volume brainstorm-cell.com (BCLI)|Projected Sales Volume CARA (Cara Therapeutics)|CHRO - Company Future Sales Volume|ELYM: Company Future Sales Volume|Company Future Revenue ITCI (Intra-Cellular Therapies)|LBPH: Projected Sales Volume|MRNS - Company Future Sales|Company Projected Revenue NKGen Biotech|Company Future Sales Volume NeuroBo Pharmaceuticals Inc (NRBO)|Company Projected Revenue Sage Therapeutics, Inc (SAGE)|Company Future Sales Volume Synaptogenix, Inc SNPX|Trevena, Inc. - Company Future Sales Volume|Projected Sales Volume Vigil Neuroscience Inc. VIGL|WENA - Company Projected Revenue|CERE (Cerevel Therapeutics Inc) - Company Revenue Forecast
